Major Pharmaceuticals Fexofenadine Tablets Recalled for Failed Impurities

Summary

The Harvard Drug Group is recalling 2,239 bottles of Major Pharmaceuticals Fexofenadine Hydrochloride Tablets (60 mg), a generic version of the allergy medication Allegra. This recall was initiated because the tablets failed to meet specifications for impurities and degradation, meaning the medication may have broken down over time. No incidents or injuries have been reported to date. Affected bottles contain 500 tablets each and were distributed nationwide.

Risk

When a medication fails impurity or degradation specifications, it means the active ingredient may have chemically broken down or contains unwanted substances. This can result in the medication being less effective at treating allergy symptoms or potentially causing unexpected side effects from the degradation products.

Additional Information